THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Stock
Total 13F shares
1,844,142
Share change
+154,956
Total reported value
$835,005
Price per share
$0.45
Number of holders
15
Value change
+$69,567
Number of buys
8
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q3 2019

As of 30 Sep 2019, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,844,142 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, WEDBUSH SECURITIES INC, GOLDMAN SACHS GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, Snowden Capital Advisors LLC, 683 Capital Management, LLC, BlackRock Inc., and UBS Group AG. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.